The evolution of pharmacy practice researchPart I: Time to implement the evidence
In this editorial, we bring together two leading pharmacy research journals, the International Journal of Pharmacy Practice and the Canadian Pharmacists Journal, to take stock of the current evidence on the effectiveness of pharmacists' contribution to patient care and make recommendations for future areas of research.
The role of pharmacists has been changing globally over the past 30 years, moving away from a technical dispensing role to a more holistic cognitive role that begins to optimize the use of the full range of pharmacist competencies acquired during basic and advanced training. The drivers for this change are multifactorial but include the increasing needs and demands of an ageing population, sustainability of the traditional physician-nurse led health care workforce, increasing use of pharmacological approaches as the mainstay of disease management and need to increase the efficient and effective use of health care budgets. Underlining the direction of the change has been evidence derived from research studies confirming that the care provided by pharmacists is generally equivalent to and sometimes better than usual care. A recently published Cochrane review concluded that "some services provided by pharmacists can have positive effects on patient health, including improved management of blood pressure and physical function, " while emphasizing the challenges from the heterogeneity of the identified studies and risk of bias in some.
1 Similarly, another Cochrane review focusing solely on hypertension concluded that "pharmacist-led care may be a promising way of improving control in patients with hypertension, with the majority of RCTs being associated with improved blood pressure control, improved systolic blood pressure and more modestly improved diastolic blood pressure, but these interventions require further evaluation. " 2 Likewise, Santschi et al.
showed an average reduction of 7.6/3.9 mmHg over 39 trials of pharmacist care vs usual care. 3 Finally, a third Cochrane review, on prescribing by other health care professionals, concluded that "with appropriate training and support, nurses and pharmacists are able to prescribe medicines as part of managing a range of conditions to achieve comparable health management outcomes to doctors. " 4 The body of research exploring the expanded scope of pharmacy practice is large, but as the Cochrane reviews and others have highlighted, many reports are small-scale nonrandomized studies or, when a randomized controlled trial is reported, there is insufficient detail of the intervention or EDITORIAL its implementation to allow replication or to make definitive recommendations. Nonetheless, across this diverse and heterogeneous literature, there is little to suggest that when pharmacists take on roles previously delivered by another health care professional, outcomes are worse than before; indeed, they are often better. Therefore, it is not surprising that in some countries, notably the United Kingdom and Canada, and to a lesser extent the United States and Australasia, pharmacists are increasingly recognized as integral to the core health care team, delivering frontline "first port of call" and supportive services.
Given the strong evidence for pharmacist care on improving patient outcomes, it follows that the next step is to apply this knowledge to our patient care in all jurisdictions. Stated another way, what all patients need is to be able to receive a full scope of pharmacist care (Figure 1) . 5 Full scope of pharmacist care means these core services: injections, prescribing, laboratory testing and disease management. 5 However, such services
are not widely available due to lack of implementation and health system failures, including restrictive legislation governing scope of practice. But shouldn't a full scope of pharmacist practice be defined by evidence rather than outdated legislation? And not just in certain jurisdictions-this should be the universal standard for scope of core pharmacy practice. Given the above, it is our societal duty to promote the delivery of the full scope of pharmacist care to all populations. Furthermore, extending capacity within health care teams by allowing pharmacists to deliver their full range of professional competencies will improve access to care internationally.
Pharmacists are the experts in medicines, and adding this specific expertise in medicines and their use to their generic health care skills means they uniquely contribute to patient care. To achieve our vision for pharmacy, we need to better understand how to attain successful organizational change when extending the role of pharmacists in a meaningful and integrated way. In many countries (e.g., some European countries), pharmacy colleagues are delivering a wide range of services, but these are in parallel to the mainstream health care service. These services are often only available on a private basis or are dependent on final medical sign-off. We need IMPLEMENTATION and INTEGRATION of the full scope of autonomous practice that we know works.
We do not need more small studies, often mistakenly labelled as pilot studies, or obsequious surveys of what pharmacists and physicians think, unless these are informing subsequent implementation plans. Further, we shouldn't spend precious and scarce health services research money on more trials repeating what has already been done, with only subtle changes of context. The priority for funding and pharmacy health service research should be on implementation science.
We need to be bold and resolute. We might not get it perfectly the first time (as pharmacists are wont to do), but it is better than the status quo and it moves us forward. Do what patients need and want-give them the full scope of pharmacist practice.
Remember our societal responsibility. History will judge us on what we do now, so we can either be at the forefront of patient care or fade into an irrelevant oblivion. Your choice. ■ This editorial was published simultaneously by CPJ and the International Journal of Pharmacy Practice.
Delay using cannabis as late as possible in life, ideally not before adulthood.
All rights reserved. © 2018 Centre for Addiction and Mental Health. Canada's Lower-Risk Cannabis Use Guidelines (LRCUG).
Avoid using if you're pregnant, or if you or family members have a history of psychosis or substance use problems.
If you do smoke, avoid deep inhalation or breath-holding.
Stay away from synthetic cannabis products, such as K2 or Spice.
Use cannabis in ways that don't involve smoking -choose less risky methods of using like vaping or ingesting.
Choose low-potency products -those with low THC and/or high CBD content. Don't operate a vehicle or machinery while impaired by cannabis. Wait at least 6 hours after using. Remember that combining alcohol and cannabis makes you more impaired.
Occasional use, such as one day per week or less, is better than regular use.
When using cannabis, be considerate of the health and safety concerns of those around you. Don't hesitate to seek support from a health professional if you need help controlling your cannabis use, if you have withdrawal symptoms or if your use is affecting your life.
Your actions add up. The more risks you take, the more likely you are to harm your health.
Cannabis & Your Health 10 WAYS to Reduce Risks When Using
Not using cannabis at all is still the best way to protect your health (unless you use with a medical recommendation).
Cannabis use is now legal for adults, but it does have health risks. If you use non-medically, you can make informed choices for safer use.
Endorsed by CPhA Retardez la consommation de cannabis jusqu'au plus tard possible dans la vie et ce, idéalement, après que vous aurez atteint l'âge adulte. La consommation de cannabis est maintenant légale pour les adultes, mais elle comporte des risques pour la santé. Si vous ne le consommez pas pour des raisons médicales, vous pouvez faire des choix éclairés pour une consommation plus sûre.
